HEADER PROTEIN BINDING 30-MAY-07 2Q3F TITLE X-RAY CRYSTAL STRUCTURE OF PUTATIVE HUMAN RAS-RELATED GTP TITLE 2 BINDING D IN COMPLEX WITH GMPPNP COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAS-RELATED GTP-BINDING PROTEIN D; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RAG D; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RRAGD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: P28A-LIC KEYWDS STRUCTURAL GENOMICS, GTP-BINDING, RRAGD, STRUCTURAL KEYWDS 2 GENOMICS CONSORTIUM, SGC, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR A.M.MULICHAK,W.M.RABEH,W.TEMPEL,L.NEDYALKOVA,R.LANDRY, AUTHOR 2 C.H.ARROWSMITH,A.M.EDWARDS,M.SUNDSTROM,J.WEIGELT,L.J.KEEFE, AUTHOR 3 A.BOCHKAREV,H.PARK,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 2 24-FEB-09 2Q3F 1 VERSN REVDAT 1 12-JUN-07 2Q3F 0 JRNL AUTH A.M.MULICHAK,W.M.RABEH,W.TEMPEL,L.NEDYALKOVA, JRNL AUTH 2 R.LANDRY,C.H.ARROWSMITH,A.M.EDWARDS,M.SUNDSTROM, JRNL AUTH 3 J.WEIGELT,L.J.KEEFE,A.BOCHKAREV,H.PARK JRNL TITL CRYSTAL STRUCTURE OF HUMAN RAS-RELATED GTP-BINDING JRNL TITL 2 D. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 21895 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1065 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2876 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 90 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.28 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.12 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.81 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q3F COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAY-07. REMARK 100 THE RCSB ID CODE IS RCSB043099. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97942, 1.0 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24803 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05400 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.54200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 31% PEG4000, 0.2M SODIUM ACETATE REMARK 280 AND 0.1M TRIS HCL, PH 8.4, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.56500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 40 REMARK 465 GLU A 41 REMARK 465 GLY B 40 REMARK 465 GLU B 41 REMARK 465 PRO B 220 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 42 CG1 CG2 REMARK 470 ARG A 53 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 92 CG1 CG2 REMARK 470 ASP A 104 CG OD1 OD2 REMARK 470 PHE A 105 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 168 CG OD1 OD2 REMARK 470 HIS A 169 CG ND1 CD2 CE1 NE2 REMARK 470 VAL B 42 CG1 CG2 REMARK 470 LYS B 148 CG CD CE NZ REMARK 470 ASP B 167 CG OD1 OD2 REMARK 470 GLU B 172 CG CD OE1 OE2 REMARK 470 LYS B 192 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS B 66 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 91 -71.25 -139.05 REMARK 500 ASP A 104 59.47 -69.58 REMARK 500 ASP A 107 85.49 -161.61 REMARK 500 PRO A 108 37.08 -76.79 REMARK 500 ASP A 167 30.63 -61.04 REMARK 500 ASP A 168 -41.89 -143.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 57 OG REMARK 620 2 THR A 78 OG1 84.1 REMARK 620 3 HOH A 406 O 89.3 96.4 REMARK 620 4 HOH A 408 O 87.6 85.6 176.2 REMARK 620 5 GNP A 401 O1G 169.7 85.6 90.6 92.9 REMARK 620 6 GNP A 401 O2B 95.0 173.1 90.5 87.5 95.3 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 302 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 57 OG REMARK 620 2 THR B 78 OG1 77.9 REMARK 620 3 HOH B 425 O 83.9 93.7 REMARK 620 4 HOH B 415 O 79.6 82.1 163.5 REMARK 620 5 GNP B 402 O2B 93.9 171.4 88.0 93.9 REMARK 620 6 GNP B 402 O1G 167.3 89.5 99.2 96.8 98.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 301 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 302 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNP A 401 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNP B 402 DBREF 2Q3F A 41 220 UNP Q9NQL2 RRAGD_HUMAN 60 239 DBREF 2Q3F B 41 220 UNP Q9NQL2 RRAGD_HUMAN 60 239 SEQADV 2Q3F GLY A 40 UNP Q9NQL2 CLONING ARTIFACT SEQADV 2Q3F MSE A 49 UNP Q9NQL2 MET 68 MODIFIED RESIDUE SEQADV 2Q3F MSE A 67 UNP Q9NQL2 MET 86 MODIFIED RESIDUE SEQADV 2Q3F MSE A 114 UNP Q9NQL2 MET 133 MODIFIED RESIDUE SEQADV 2Q3F MSE A 133 UNP Q9NQL2 MET 152 MODIFIED RESIDUE SEQADV 2Q3F GLY B 40 UNP Q9NQL2 CLONING ARTIFACT SEQADV 2Q3F MSE B 49 UNP Q9NQL2 MET 68 MODIFIED RESIDUE SEQADV 2Q3F MSE B 67 UNP Q9NQL2 MET 86 MODIFIED RESIDUE SEQADV 2Q3F MSE B 114 UNP Q9NQL2 MET 133 MODIFIED RESIDUE SEQADV 2Q3F MSE B 133 UNP Q9NQL2 MET 152 MODIFIED RESIDUE SEQRES 1 A 181 GLY GLU VAL LYS PRO ARG ILE LEU LEU MSE GLY LEU ARG SEQRES 2 A 181 ARG SER GLY LYS SER SER ILE GLN LYS VAL VAL PHE HIS SEQRES 3 A 181 LYS MSE SER PRO ASN GLU THR LEU PHE LEU GLU SER THR SEQRES 4 A 181 ASN LYS ILE CYS ARG GLU ASP VAL SER ASN SER SER PHE SEQRES 5 A 181 VAL ASN PHE GLN ILE TRP ASP PHE PRO GLY GLN ILE ASP SEQRES 6 A 181 PHE PHE ASP PRO THR PHE ASP TYR GLU MSE ILE PHE ARG SEQRES 7 A 181 GLY THR GLY ALA LEU ILE PHE VAL ILE ASP SER GLN ASP SEQRES 8 A 181 ASP TYR MSE GLU ALA LEU ALA ARG LEU HIS LEU THR VAL SEQRES 9 A 181 THR ARG ALA TYR LYS VAL ASN THR ASP ILE ASN PHE GLU SEQRES 10 A 181 VAL PHE ILE HIS LYS VAL ASP GLY LEU SER ASP ASP HIS SEQRES 11 A 181 LYS ILE GLU THR GLN ARG ASP ILE HIS GLN ARG ALA ASN SEQRES 12 A 181 ASP ASP LEU ALA ASP ALA GLY LEU GLU LYS ILE HIS LEU SEQRES 13 A 181 SER PHE TYR LEU THR SER ILE TYR ASP HIS SER ILE PHE SEQRES 14 A 181 GLU ALA PHE SER LYS VAL VAL GLN LYS LEU ILE PRO SEQRES 1 B 181 GLY GLU VAL LYS PRO ARG ILE LEU LEU MSE GLY LEU ARG SEQRES 2 B 181 ARG SER GLY LYS SER SER ILE GLN LYS VAL VAL PHE HIS SEQRES 3 B 181 LYS MSE SER PRO ASN GLU THR LEU PHE LEU GLU SER THR SEQRES 4 B 181 ASN LYS ILE CYS ARG GLU ASP VAL SER ASN SER SER PHE SEQRES 5 B 181 VAL ASN PHE GLN ILE TRP ASP PHE PRO GLY GLN ILE ASP SEQRES 6 B 181 PHE PHE ASP PRO THR PHE ASP TYR GLU MSE ILE PHE ARG SEQRES 7 B 181 GLY THR GLY ALA LEU ILE PHE VAL ILE ASP SER GLN ASP SEQRES 8 B 181 ASP TYR MSE GLU ALA LEU ALA ARG LEU HIS LEU THR VAL SEQRES 9 B 181 THR ARG ALA TYR LYS VAL ASN THR ASP ILE ASN PHE GLU SEQRES 10 B 181 VAL PHE ILE HIS LYS VAL ASP GLY LEU SER ASP ASP HIS SEQRES 11 B 181 LYS ILE GLU THR GLN ARG ASP ILE HIS GLN ARG ALA ASN SEQRES 12 B 181 ASP ASP LEU ALA ASP ALA GLY LEU GLU LYS ILE HIS LEU SEQRES 13 B 181 SER PHE TYR LEU THR SER ILE TYR ASP HIS SER ILE PHE SEQRES 14 B 181 GLU ALA PHE SER LYS VAL VAL GLN LYS LEU ILE PRO MODRES 2Q3F MSE A 49 MET SELENOMETHIONINE MODRES 2Q3F MSE A 67 MET SELENOMETHIONINE MODRES 2Q3F MSE A 114 MET SELENOMETHIONINE MODRES 2Q3F MSE A 133 MET SELENOMETHIONINE MODRES 2Q3F MSE B 49 MET SELENOMETHIONINE MODRES 2Q3F MSE B 67 MET SELENOMETHIONINE MODRES 2Q3F MSE B 114 MET SELENOMETHIONINE MODRES 2Q3F MSE B 133 MET SELENOMETHIONINE HET MSE A 49 8 HET MSE A 67 8 HET MSE A 114 8 HET MSE A 133 8 HET MSE B 49 8 HET MSE B 67 8 HET MSE B 114 8 HET MSE B 133 8 HET MG A 301 1 HET MG B 302 1 HET GNP A 401 32 HET GNP B 402 32 HETNAM MSE SELENOMETHIONINE HETNAM MG MAGNESIUM ION HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 3 MG 2(MG 2+) FORMUL 5 GNP 2(C10 H17 N6 O13 P3) FORMUL 7 HOH *90(H2 O) HELIX 1 1 GLY A 55 LYS A 66 1 12 HELIX 2 2 SER A 68 LEU A 75 5 8 HELIX 3 3 ASP A 111 GLY A 118 1 8 HELIX 4 4 TYR A 132 ASN A 150 1 19 HELIX 5 5 VAL A 162 LEU A 165 5 4 HELIX 6 6 ASP A 168 ALA A 188 1 21 HELIX 7 7 HIS A 205 LYS A 217 1 13 HELIX 8 8 GLY B 55 HIS B 65 1 11 HELIX 9 9 SER B 68 LEU B 75 5 8 HELIX 10 10 ASP B 111 GLY B 118 1 8 HELIX 11 11 TYR B 132 ASN B 150 1 19 HELIX 12 12 SER B 166 ALA B 188 1 23 HELIX 13 13 HIS B 205 LYS B 217 1 13 SHEET 1 A 6 CYS A 82 VAL A 86 0 SHEET 2 A 6 PHE A 94 ASP A 98 -1 O PHE A 94 N VAL A 86 SHEET 3 A 6 ARG A 45 GLY A 50 1 N LEU A 48 O TRP A 97 SHEET 4 A 6 THR A 119 ASP A 127 1 O ILE A 123 N LEU A 47 SHEET 5 A 6 ASN A 154 HIS A 160 1 O PHE A 158 N ILE A 126 SHEET 6 A 6 LEU A 195 THR A 200 1 O TYR A 198 N ILE A 159 SHEET 1 B 6 CYS B 82 VAL B 86 0 SHEET 2 B 6 PHE B 94 ASP B 98 -1 O ASP B 98 N CYS B 82 SHEET 3 B 6 ARG B 45 MSE B 49 1 N ILE B 46 O GLN B 95 SHEET 4 B 6 THR B 119 ASP B 127 1 O ILE B 123 N MSE B 49 SHEET 5 B 6 ASN B 154 HIS B 160 1 O GLU B 156 N PHE B 124 SHEET 6 B 6 LEU B 195 LEU B 199 1 O SER B 196 N VAL B 157 LINK OG SER A 57 MG MG A 301 1555 1555 2.10 LINK OG1 THR A 78 MG MG A 301 1555 1555 2.15 LINK OG SER B 57 MG MG B 302 1555 1555 2.21 LINK OG1 THR B 78 MG MG B 302 1555 1555 2.19 LINK MG MG A 301 O HOH A 406 1555 1555 2.27 LINK MG MG A 301 O HOH A 408 1555 1555 2.19 LINK MG MG B 302 O HOH B 425 1555 1555 2.14 LINK MG MG B 302 O HOH B 415 1555 1555 2.11 LINK MG MG A 301 O1G GNP A 401 1555 1555 2.19 LINK MG MG A 301 O2B GNP A 401 1555 1555 2.08 LINK MG MG B 302 O2B GNP B 402 1555 1555 2.03 LINK MG MG B 302 O1G GNP B 402 1555 1555 1.97 LINK C LEU A 48 N MSE A 49 1555 1555 1.33 LINK C MSE A 49 N GLY A 50 1555 1555 1.33 LINK C LYS A 66 N MSE A 67 1555 1555 1.33 LINK C MSE A 67 N SER A 68 1555 1555 1.33 LINK C GLU A 113 N MSE A 114 1555 1555 1.33 LINK C MSE A 114 N ILE A 115 1555 1555 1.33 LINK C TYR A 132 N MSE A 133 1555 1555 1.33 LINK C MSE A 133 N GLU A 134 1555 1555 1.33 LINK C LEU B 48 N MSE B 49 1555 1555 1.33 LINK C MSE B 49 N GLY B 50 1555 1555 1.33 LINK C LYS B 66 N MSE B 67 1555 1555 1.33 LINK C MSE B 67 N SER B 68 1555 1555 1.33 LINK C GLU B 113 N MSE B 114 1555 1555 1.33 LINK C MSE B 114 N ILE B 115 1555 1555 1.33 LINK C TYR B 132 N MSE B 133 1555 1555 1.33 LINK C MSE B 133 N GLU B 134 1555 1555 1.33 SITE 1 AC1 5 SER A 57 THR A 78 GNP A 401 HOH A 406 SITE 2 AC1 5 HOH A 408 SITE 1 AC2 5 SER B 57 THR B 78 GNP B 402 HOH B 415 SITE 2 AC2 5 HOH B 425 SITE 1 AC3 22 ARG A 52 ARG A 53 SER A 54 GLY A 55 SITE 2 AC3 22 LYS A 56 SER A 57 SER A 58 THR A 72 SITE 3 AC3 22 LEU A 73 THR A 78 GLY A 101 GLN A 129 SITE 4 AC3 22 HIS A 160 LYS A 161 ASP A 163 SER A 201 SITE 5 AC3 22 ILE A 202 MG A 301 HOH A 406 HOH A 408 SITE 6 AC3 22 HOH A 422 HOH A 430 SITE 1 AC4 24 LEU B 51 ARG B 52 ARG B 53 SER B 54 SITE 2 AC4 24 GLY B 55 LYS B 56 SER B 57 SER B 58 SITE 3 AC4 24 THR B 72 LEU B 73 THR B 78 GLY B 101 SITE 4 AC4 24 HIS B 160 LYS B 161 ASP B 163 SER B 201 SITE 5 AC4 24 ILE B 202 TYR B 203 MG B 302 HOH B 410 SITE 6 AC4 24 HOH B 415 HOH B 417 HOH B 425 HOH B 440 CRYST1 47.730 67.130 66.360 90.00 110.92 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020951 0.000000 0.008009 0.00000 SCALE2 0.000000 0.014896 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016133 0.00000